According to the data disclosed by the General Administration of Customs on the 13th, the total import and export value of China's trade in goods exceeded the 4 billion yuan mark for the first time in 2022, reaching 42.
07 trillion yuan, an increase of 7.
7% over 2021, and the scale hit a record high
.
Among them, from the perspective of export products, China's industrial products exports will increase by 9.
9% in 2022, driving the overall export growth by 9.
4 percentage points
.
It is understood that industry is generally divided into light industry and heavy industry according to the nature of products, of which light industry mainly refers to the industry that provides consumer goods and makes hand tools, and heavy industry refers to the industry that provides the main means of production for all sectors of the national economy, such as mining (felling) industry, raw material industry, processing industry, etc.
, including pharmaceutical machinery and equipment manufacturing industry are all processing industries
in heavy industry.
So, in the context of China's industrial products export growth of nearly 10% in 2022, how is the export business of domestic pharmaceutical machinery enterprises developing?
Pharmaceutical machine industry (Image source: Pharmaceutical Network)
The international market has become an important market for the layout of pharmaceutical machine enterprises
Canaan Technology said on the investor interactive platform on January 9 that the international market is an important market for the company's business, and the company will pay close attention
to relevant policy notices and market dynamics.
It is reported that Canaan Science and Technology has formed its own core products after years of exploration and continuous investment, and its industrial scale, independent innovation ability, research and development ability, etc.
are dominant in domestic pharmaceutical enterprises, and gradually move to the international stage, accumulating a good brand effect
.
According to the 2022 half-year report, Canaan Technology accounted for 94.
01% in China and 5.
09% in overseas business
.
Chutian Technology product sales are divided into domestic sales and international sales, of which domestic sales is a direct sales model for end customers, and international sales is a sales model
for end customers and agents.
The company has two major sales and service systems, domestic and international, the current domestic sales scale is greater than the international, and the future planning international sales are greater than the domestic
.
It is reported that Chutian Technology plans to account for 40%-50%
of the total revenue by about 2025.
In order to achieve the plan, Chutian Technology is vigorously exploring overseas markets, and the 2022 half-year report shows that the sales expenses in the reporting period increased by 10.
27% compared with the previous year, on the one hand, the company increased its layout in the international market, resulting in increased expenses such as travel expenses, office expenses, advertising, exhibition fees and bidding service fees
.
In terms of international layout, Chutian Technology merged Romaco Group, an international supplier of German equipment, into a listed company in 2020, enhancing the company's international market position
.
Although affected by the epidemic and global supply chain tensions, Romaco Group's operating income from January to June 2022 decreased by 23.
34% and net profit decreased by 405.
08%
from the same period of the previous year.
Dongfulong also adheres to the international route, and has changed from only providing parts processing services to providing complete equipment services
.
In April 2022, the company said in an institutional survey that internationally, the company set up subsidiaries in Hong Kong, India, Indonesia, Turkey, Australia, Dubai, Vietnam and South Africa to open up the local market
.
In 2021, the proportion of the company's overseas revenue continued to increase to nearly 25%.
It is mainly stimulated by several factors
From the analysis point of view, the export business of pharmaceutical machinery enterprises has developed rapidly and has become an important market for the layout of pharmaceutical machinery enterprises mainly in the following aspects
.
First, the growth of demand in the pharmaceutical market is pulled
.
The demand of the pharmaceutical equipment industry is a rigid demand, in the context of the aging of the global society and the continuous improvement of residents' health awareness, the rapid growth of drug sales demand has driven the rapid development of the pharmaceutical industry, especially the biological pharmaceutical industry has ushered in rapid development, stimulated by these factors, the upstream pharmaceutical equipment industry has ushered in opportunities
.
China's pharmaceutical equipment industry has also ushered in a good opportunity for rapid development in recent years, and pharmaceutical machinery companies represented by the head have risen
rapidly.
Second, the level of domestic pharmaceutical machinery enterprises continues to improve, with the advantages of high cost performance and good after-sales service, accelerate import substitution, and gradually win the "heart" of overseas customers
.
For example, Canaan Technology's 2022 semi-annual report mentioned that some of the company's products have reached the international advanced level, of which the quality and performance of core products have improved year by year, similar to foreign advanced products, and have the strength of import substitution, and the price is much lower than that of foreign imported equipment, which meets the multiple needs of customers for process accuracy, stable performance and economic cost, and has strong competitiveness
in cost performance.
It is reported that Canaan science and technology products and services have covered international and domestic enterprises in more than 30 countries and regions around the world, forming a solid customer base
.
Third, the policy also strongly supports
pharmaceutical enterprises.
The pharmaceutical equipment manufacturing industry has long been one of the key development areas of the pharmaceutical industry and belongs to the field
of industrial policy support.
In recent years, including the "14th Five-Year Plan" National Health Plan", "14th Five-Year Plan" Bio-economy Development Plan, "14th Five-Year Plan" Chinese Medicine Development Plan and other policies conducive to the development of the pharmaceutical industry have been issued one after another, which will have a good role in promoting the development of China's pharmaceutical equipment industry and create a better policy environment
for the development of enterprises.
In addition to the national level, local policies also support innovative and high-quality development enterprises, sending real money to related enterprises
.
For example, Canaan Technology announced on January 5 that the company and its holding subsidiaries have received a total of RMB 8.
323 million in various government subsidies from July 1, 2022 to December 31, 2022, including quality and brand incentives, value-added tax refunds for software products, and subsidies for key projects of special development funds
.
Among them, the government subsidy fund for VAT refund of software products is RMB 2,741,300, and the other government subsidy fund is RMB 5,581,700
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
